UK

Ofcom Fines Porn Company £1.35m for Lack of Age Checks

Ofcom has fined pornographic company 8579 LLC £1.35 million for failing to implement effective age verification measures as required by the UK's Online Safety Act. The company also received a £50,000 fine for failing to respond to a legally binding information request. These actions underscore Ofcom's commitment to protecting children online.

International Data Protection Authorities Joint Statement on AI Imagery Risks

Sixty-one international data protection authorities have issued a joint statement outlining privacy risks associated with AI-generated imagery. The statement addresses concerns about the creation of realistic images and videos of individuals without consent, particularly highlighting potential harms to children. It urges responsible AI development and deployment.

MHRA Licenses Brensocatib for Non-Cystic Fibrosis Bronchiectasis

The MHRA has granted a marketing authorisation for brensocatib (Brinsupri), the first medicine specifically designed to treat non-cystic fibrosis bronchiectasis (NCFB) in patients aged 12 years and older. This marks a significant advancement in treatment options for NCFB patients in the UK.

MHRA Class 2 Medicines Recall: KidNaps Melatonin Oral Solution

The MHRA has issued a Class 2 medicines recall for all batches of KidNaps Melatonin 1mg in 1ml Oral Solution due to out-of-specification stability results. Sterling Pharmaceuticals Ltd and Veriton Pharma Ltd are conducting the recall at the wholesaler and pharmacy level.

MHRA Statement on PATHWAYS Puberty Blocker Trial Safety

The MHRA has issued a statement regarding the PATHWAYS puberty blocker trial, expressing concerns about participant wellbeing and initiating scientific dialogue with the trial sponsor, King's College London. The agency is applying high scrutiny to ensure the safety of potential child and young person participants.

MHRA Approves Zanidatamab for HER2+ Biliary Tract Cancer

The MHRA has approved zanidatamab (Ziihera) for adult patients with HER2-positive biliary tract cancer that has progressed after previous treatment. This approval provides a new treatment option for a specific patient population with an unmet clinical need.

Ofcom Telecoms and Pay-TV Complaints Q3 2025

Ofcom has published its latest figures for complaints received about major UK landline, mobile, broadband, and pay-TV providers for Q3 2025. The report indicates that complaint levels remained similar to the previous quarter across all service types, with specific providers identified as generating the most and fewest complaints.

ICO v. DSG Retail - Data Protection Security Ruling

The UK's Information Commissioner's Office (ICO) has won a Court of Appeal case against DSG Retail Limited, reinstating a £500,000 fine for a 2020 data breach. The ruling clarifies that organisations must secure all personal data, regardless of whether individuals can be identified from exfiltrated data.

MHRA: UK Medical Device Testing Hits Record High, Backs AI

The UK's MHRA reported a 17% increase in approved medical device clinical investigations in 2025. The agency is implementing measures to support innovation, including a fee waiver pilot for small firms and enhanced support for AI and neurotechnology.

MHRA Medical Device Safety Notices

The MHRA has issued a list of eight medical device safety notices published between February 9-13, 2026. These notices cover various devices including ventilator circuits, tissue reconstructive material, and PET/CT scanners. The MHRA publishes these for informational purposes.